Takasago International Corporation (JP:4914)
:4914
Want to see JP:4914 full AI Analyst Report?
Top Page
Takasago International Corporation
(4914)
Select Model
Select Model
Rating:57Neutral
Price Target:
¥1,151.00
▼(-21.91% Downside)
Action:Reiterated
Date:05/19/26
The score is held back primarily by deteriorating cash flow and weaker 2026 profitability, alongside a clearly bearish technical trend. These negatives are partially offset by a solid capital structure and supportive valuation (moderate P/E and high dividend yield).
Positive Factors
Balance sheet resilience
Manageable leverage and rising equity give the company financial flexibility to fund R&D and working-capital needs without large refinancing risk. A stronger balance sheet supports resilience through cyclical demand swings and enables selective investment or M&A over the next several quarters.
Negative Factors
Sharp cash flow deterioration
A large drop in operating cash and a deeply negative free cash flow point to weaker cash conversion and higher working-capital or capex demands. Persistent cash weakness would constrain dividends, capex funding, and strategic flexibility absent balance-sheet remedies or improved operating cash generation.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet resilience
Manageable leverage and rising equity give the company financial flexibility to fund R&D and working-capital needs without large refinancing risk. A stronger balance sheet supports resilience through cyclical demand swings and enables selective investment or M&A over the next several quarters.
Read all positive factors
Takasago International Corporation (4914) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥112.27B
Dividend Yield3.77%
Average Volume (3M)150.45K
Price to Earnings (P/E)12.1
Beta (1Y)0.67
Revenue Growth-1.80%
EPS Growth-28.55%
CountryJP
Employees4,041
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)125.81
Shares Outstanding100,761,980
10 Day Avg. Volume159,350
30 Day Avg. Volume150,450
Financial Highlights & Ratios
PEG Ratio-0.42
Price to Book (P/B)0.75
Price to Sales (P/S)0.51
P/FCF Ratio-7.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Takasago International Corporation Business Overview & Revenue Model
Company Description
Takasago International Corporation manufactures and sells flavors, fragrances, aroma ingredients, and other fine chemicals. The company offers flavors for use in various beverages comprising fruit juices, carbonated drinks, coffee and tea flavored...
How the Company Makes Money
Takasago makes money primarily by selling flavors and fragrance materials to business customers (B2B) that manufacture consumer goods. Its core revenue streams generally consist of (1) flavor sales: supplying flavor compounds and systems used to i...
Takasago International Corporation Financial Statement Overview
Summary
Income Statement
60
Neutral
Balance Sheet
68
Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 231.69B | 225.09B | 229.21B | 195.94B | 186.79B | 162.44B |
| Gross Profit | 77.79B | 72.91B | 77.40B | 56.48B | 54.44B | 51.13B |
| EBITDA | 23.00B | 16.89B | 23.04B | 10.18B | 13.33B | 15.72B |
| Net Income | 12.26B | 9.53B | 13.32B | 2.70B | 7.39B | 8.91B |
Balance Sheet | ||||||
| Total Assets | 250.58B | 271.15B | 262.17B | 228.43B | 212.08B | 196.84B |
| Cash, Cash Equivalents and Short-Term Investments | 13.48B | 19.58B | 35.59B | 18.33B | 14.97B | 16.15B |
| Total Debt | 53.46B | 62.77B | 60.78B | 46.73B | 44.78B | 43.73B |
| Total Liabilities | 108.23B | 115.09B | 115.78B | 97.55B | 90.12B | 86.54B |
| Stockholders Equity | 140.33B | 153.42B | 144.20B | 129.06B | 120.21B | 108.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -14.99B | 7.62B | 3.97B | 807.00M | 4.80B |
| Operating Cash Flow | 0.00 | 4.27B | 18.92B | 10.01B | 5.82B | 11.57B |
| Investing Cash Flow | 0.00 | -16.22B | -9.13B | -6.82B | -3.28B | -7.26B |
| Financing Cash Flow | 0.00 | -4.64B | 6.88B | -453.00M | -2.04B | -2.36B |
Takasago International Corporation Technical Analysis
Negative
1474.00
Price Trends
1197.61
Negative
1320.63
Negative
1412.33
Negative
Market Momentum
-15.40
Positive
38.33
Neutral
31.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4914, the sentiment is Negative. The current price of 1474 is above the 20-day moving average (MA) of 1181.00, above the 50-day MA of 1197.61, and above the 200-day MA of 1412.33, indicating a bearish trend. The MACD of -15.40 indicates Positive momentum. The RSI at 38.33 is Neutral, neither overbought nor oversold. The STOCH value of 31.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4914.
Takasago International Corporation Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥108.88B | 18.70 | 15.07% | 1.74% | 7.82% | 64.90% | |
74 Outperform | ¥21.73B | 6.70 | ― | 1.82% | -1.80% | 3.81% | |
73 Outperform | ¥75.50B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
70 Outperform | ¥126.18B | 10.95 | 5.56% | 2.59% | 1.68% | 0.29% | |
64 Neutral | ¥26.09B | 11.36 | ― | 4.27% | 2.37% | -16.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
57 Neutral | ¥112.27B | 12.13 | ― | 3.77% | -1.80% | -28.55% |
* Basic Materials Sector Average
JP:4914
Takasago International Corporation
1,120.00
-100.79
-8.26%
JP:4958
T Hasegawa Co
3,070.00
323.52
11.78%
JP:4187
Osaka Organic Chemical Industry Ltd.
4,915.00
2,549.42
107.77%
JP:4116
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
1,044.00
303.75
41.03%
JP:4968
Arakawa Chemical Industries,Ltd.
1,315.00
246.17
23.03%
JP:4977
Nitta Gelatin Inc.
1,200.00
428.48
55.54%
Takasago International Corporation Corporate Events
Takasago Revamps Board and Executive Lineup to Sharpen Global Operations
May 15, 2026
Takasago International Corporation announced a broad slate of leadership changes, including the confirmation of Satoshi Masumura as chairman and CEO and the appointment of Naoki Mizuno as president and COO, alongside a refreshed board that adds se...
Takasago Reshapes Top Management, Promotes Mizuno to President and COO
May 15, 2026
Takasago International Corporation announced a leadership reshuffle following a board decision on May 15, 2026, that will take effect on June 25, 2026. President and CEO Satoshi Masumura will become representative director, chairman and CEO, while...
Takasago Profit Falls on Weaker U.S. Shipments and Delayed Fine Chemical Sales
May 15, 2026
Takasago International Corporation reported largely stable domestic flavor sales and solid demand for beverage flavors and fabric-care fragrances in China during fiscal 2025, but faced higher raw material import costs in Japan due to yen depreciat...
Takasago Profit Slumps but Equity Strengthens as China Unit Added
May 15, 2026
Takasago International reported fiscal 2026 net sales of ¥225.1 billion, down 1.8% year on year, with operating profit plunging 47% to ¥8.1 billion and profit attributable to owners of parent falling 28.5% to ¥9.5 billion, yielding ...
Takasago Affirms Board Effectiveness, Pledges Deeper Focus on Strategy and Capital Policy
Apr 28, 2026
Takasago International Corporation has completed an internal evaluation of the effectiveness of its Board of Directors, using an anonymous questionnaire distributed to all directors and auditors to assess board composition, operations, roles, indi...
Takasago Books ¥2.543 Billion Extraordinary Gain From Sale of Hisamitsu Shares
Feb 24, 2026
Takasago International Corporation has sold all 444,038 shares it held in Hisamitsu Pharmaceutical Co., Inc., including those held via the Hisamitsu Pharmaceutical Shareholding Association, into a tender offer conducted by Taiyo Kosan Co., Inc. Th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.